Tumor-Specific Success Probabilities and Factors Associated With Phase III Trials in Oncology Drug Development.
Saved in:
| Title: | Tumor-Specific Success Probabilities and Factors Associated With Phase III Trials in Oncology Drug Development. |
|---|---|
| Authors: | Yamamoto K; Regulatory Science, Graduate School of Pharmaceutical Sciences, Meiji Pharmaceutical University, Tokyo, Japan.; Genmab K.K., Tokyo, Japan., Iwase A; Regulatory Science, Graduate School of Pharmaceutical Sciences, Meiji Pharmaceutical University, Tokyo, Japan., Maeda H; Regulatory Science, Graduate School of Pharmaceutical Sciences, Meiji Pharmaceutical University, Tokyo, Japan. |
| Source: | Clinical and translational science [Clin Transl Sci] 2026 Jun; Vol. 19 (6), pp. e70635. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print Cited Medium: Internet ISSN: 1752-8062 (Electronic) Linking ISSN: 17528054 NLM ISO Abbreviation: Clin Transl Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
